AIMS/HYPOTHESIS: The heritability of fasting serum insulin and glucose concentrations in non-diabetic members of multiplex hypertensive families is unknown. METHODS: We calculated the familial aggregation of fasting serum glucose and insulin concentrations and performed a genome-wide scan to assess whether quantitative trait loci contribute to these phenotypes in 2,412 non-diabetic individuals from 1,030 families enrolled in the Hypertension Genetic Epidemiology Network (HyperGEN) in the Family Blood Pressure Program. RESULTS: The heritability (+/-SE) of fasting serum insulin was 0.47+/-0.085 in European Americans and 0.28+/-0.08 in African Americans (p<0.0001 for both), after adjusting for age, sex, and BMI. A genome-wide scan for fasting serum insulin yielded a maximum log of the odds (LOD) score of 2.36 on chromosome 5 at 20 cM (p=0.0004) in European Americans, and an LOD score of 2.28 on chromosome 19 at 11 cM (p=0.0004) in African Americans. The heritability of fasting serum glucose was 0.5109+/-0.08 in the former and 0.29+/-0.09 in the latter (p<0.0003 for both) after adjusting for age, sex and BMI. A genome-wide scan for fasting serum glucose revealed a maximum LOD score of 2.07 on chromosome 5 at 26 cM (p=0.0009) in European Americans. CONCLUSIONS/ INTERPRETATION: These analyses demonstrate the marked heritability of fasting serum insulin and glucose concentrations in families enriched for the presence of members with hypertension. They suggest that genes associated with fasting serum insulin concentration are present on chromosomes 19 and 5, and that genes associated with fasting serum glucose concentration are on chromosome 5, in families enriched for hypertension.
AIMS/HYPOTHESIS: The heritability of fasting serum insulin and glucose concentrations in non-diabetic members of multiplex hypertensive families is unknown. METHODS: We calculated the familial aggregation of fasting serum glucose and insulin concentrations and performed a genome-wide scan to assess whether quantitative trait loci contribute to these phenotypes in 2,412 non-diabetic individuals from 1,030 families enrolled in the Hypertension Genetic Epidemiology Network (HyperGEN) in the Family Blood Pressure Program. RESULTS: The heritability (+/-SE) of fasting serum insulin was 0.47+/-0.085 in European Americans and 0.28+/-0.08 in African Americans (p<0.0001 for both), after adjusting for age, sex, and BMI. A genome-wide scan for fasting serum insulin yielded a maximum log of the odds (LOD) score of 2.36 on chromosome 5 at 20 cM (p=0.0004) in European Americans, and an LOD score of 2.28 on chromosome 19 at 11 cM (p=0.0004) in African Americans. The heritability of fasting serum glucose was 0.5109+/-0.08 in the former and 0.29+/-0.09 in the latter (p<0.0003 for both) after adjusting for age, sex and BMI. A genome-wide scan for fasting serum glucose revealed a maximum LOD score of 2.07 on chromosome 5 at 26 cM (p=0.0009) in European Americans. CONCLUSIONS/ INTERPRETATION: These analyses demonstrate the marked heritability of fasting serum insulin and glucose concentrations in families enriched for the presence of members with hypertension. They suggest that genes associated with fasting serum insulin concentration are present on chromosomes 19 and 5, and that genes associated with fasting serum glucose concentration are on chromosome 5, in families enriched for hypertension.
Authors: Y Hong; S J Weisnagel; T Rice; G Sun; S A Mandel; C Gu; T Rankinen; J Gagnon; A S Leon; J S Skinner; J H Wilmore; R N Bergman; C Bouchard; D C Rao Journal: Clin Genet Date: 2001-07 Impact factor: 4.438
Authors: James B Meigs; Carolien I M Panhuysen; Richard H Myers; Peter W F Wilson; L Adrienne Cupples Journal: Diabetes Date: 2002-03 Impact factor: 9.461
Authors: David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka Journal: Am J Epidemiol Date: 2002-12-01 Impact factor: 4.897
Authors: Michèle M Sale; Barry I Freedman; Carl D Langefeld; Adrienne H Williams; Pamela J Hicks; Carla J Colicigno; Stephanie R Beck; W Mark Brown; Stephen S Rich; Donald W Bowden Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: A P Gjesing; C T Ekstrøm; H Eiberg; S A Urhammer; J J Holst; O Pedersen; T Hansen Journal: Diabetologia Date: 2012-02-15 Impact factor: 10.122
Authors: Claudia H T Tam; Vincent K L Lam; Wing-Yee So; Ronald C W Ma; Juliana C N Chan; Maggie C Y Ng Journal: BMC Genet Date: 2010-02-24 Impact factor: 2.797
Authors: Annaswamy Raji; Jonathan S Williams; Paul N Hopkins; Donald C Simonson; Gordon H Williams Journal: J Clin Hypertens (Greenwich) Date: 2006-11 Impact factor: 3.738
Authors: Marguerite R Irvin; Nathan E Wineinger; Treva K Rice; Nicholas M Pajewski; Edmond K Kabagambe; Charles C Gu; Jim Pankow; Kari E North; Jemma B Wilk; Barry I Freedman; Nora Franceschini; Uli Broeckel; Hemant K Tiwari; Donna K Arnett Journal: PLoS One Date: 2011-08-25 Impact factor: 3.240
Authors: Noah Zaitlen; Bogdan Pasaniuc; Sriram Sankararaman; Gaurav Bhatia; Jianqi Zhang; Alexander Gusev; Taylor Young; Arti Tandon; Samuela Pollack; Bjarni J Vilhjálmsson; Themistocles L Assimes; Sonja I Berndt; William J Blot; Stephen Chanock; Nora Franceschini; Phyllis G Goodman; Jing He; Anselm J M Hennis; Ann Hsing; Sue A Ingles; William Isaacs; Rick A Kittles; Eric A Klein; Leslie A Lange; Barbara Nemesure; Nick Patterson; David Reich; Benjamin A Rybicki; Janet L Stanford; Victoria L Stevens; Sara S Strom; Eric A Whitsel; John S Witte; Jianfeng Xu; Christopher Haiman; James G Wilson; Charles Kooperberg; Daniel Stram; Alex P Reiner; Hua Tang; Alkes L Price Journal: Nat Genet Date: 2014-11-10 Impact factor: 38.330